Search

everythinglearnresearchcommunity

for

Search:↓

B6.Cg-Tyr c−2J Hr hr /J mice have a stronger delayed sunburn reaction and are good for UV research.

Phlorotannins from brown seaweeds may improve skin and hair health in cosmetics.

Mycophenolate mofetil may safely help restore skin color in depigmentation conditions.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

KIT's role in skin cells is not entirely independent, as other cells can influence its function.

mEphA1 receptor tyrosine kinase is important for skin and hair development and may play a role in certain diseases.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Erlotinib can cause excessive eyelash growth.

PDGF signaling is crucial for cell development, wound healing, and fluid regulation in the body.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

EGFR inhibitors for lung cancer can cause severe skin issues.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Axitinib treatment turned a man's grey hair back to black.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.